Diagnosis and management of iron deficiency anemia

Hematology/Oncology Clinics of North America

Volumn 28, Issue 4, 2014, Pages 729-745

  Powers, Jacquelyn M ^a   Buchanan, George R ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Anemia; Deficiency; IDA; Iron; Microcytic; Therapy

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRIC GLUCONATE; FERRIC ISOMALTOSIDE; FERUMOXYTOL; HEMOGLOBIN; IRON; IRON DEXTRAN; IRON SACCHARATE; MONOFER; UNCLASSIFIED DRUG;

BLOOD CELL COUNT; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE COURSE; DRUG DOSE REGIMEN; EARLY DIAGNOSIS; GROUPS BY AGE; HEMOGLOBIN DETERMINATION; HUMAN; INCIDENCE; IRON DEFICIENCY ANEMIA; IRON THERAPY; LABORATORY TEST; MICROCYTIC ANEMIA; PREVALENCE; PREVENTION; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; ANEMIA, IRON-DEFICIENCY; DISEASE MANAGEMENT;

ANEMIA, IRON-DEFICIENCY; DISEASE MANAGEMENT; HUMANS;

EID: 84904796630     PISSN: 08898588     EISSN: 15581977     Source Type: Journal    
DOI: 10.1016/j.hoc.2014.04.007     Document Type: Review

References (76)

1. Christian H.A. A sketch of the history of the treatment of chlorosis with iron. Med Library Hist J 1903, 1(3):176-180.
2. Smith N.J. Iron as a therapeutic agent in pediatric practice. J Pediatr 1958, 53(1):37-50.
3. Oski F.A. Iron deficiency in infancy and childhood. N Engl J Med 1993, 329(3):190-193.
4. de Benoist B., Hempstead R. Iron deficiency anaemia: assessment, prevention, and control. A guide for programme managers 2001, World Health Organization, Geneva, Switzerland.
5. Pearson H.A. History of pediatric hematology oncology. Pediatr Res 2002, 52(6):979-992.
6. Rockey D.C. Treatment of iron deficiency. Gastroenterology 2006, 130(4):1367-1368.
7. McLean E., Cogswell M., Egli I., et al. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993-2005. Public Health Nutr 2009, 12(4):444-454.
8. Brotanek J.M., Gosz J., Weitzman M., et al. Secular trends in the prevalence of iron deficiency among US toddlers, 1976-2002. Arch Pediatr Adolesc Med 2008, 162(4):374-381.
9. Screening for iron deficiency anemia-including iron supplementation for children and pregnant women: U.S. Preventive Services Task Force. 2006.
10. Centers for Disease Control and Prevention (CDC) Iron deficiency-United States, 1999-2000. MMWR Morb Mortal Wkly Rep 2002, 51(40):897-899.
11. Beutler E. Disorders of iron metabolism. Williams hematology 2010, The McGraw-Hill Companies, New York, Available at:, Accessed November 4, 2013. http://accessmedicine.mhmedical.com/content.aspx?bookid=358%26Sectionid%3D39835860, 8th edition. M.A. Lichtman, T.J. Kipps, U. Seligsohn (Eds.).
12. Bar-Or D. Screening for iron deficiency. N Engl J Med 1982, 307(22):1405-1406.
13. Algarin C., Peirano P., Garrido M., et al. Iron deficiency anemia in infancy: long-lasting effects on auditory and visual system functioning. Pediatr Res 2003, 53(2):217-223.
14. Lozoff B., Beard J., Connor J., et al. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev 2006, 64(5 Pt 2):S34-S43. [discussion: S72-91].
15. Kabakus N., Ayar A., Yoldas T.K., et al. Reversal of iron deficiency anemia-induced peripheral neuropathy by iron treatment in children with iron deficiency anemia. J Trop Pediatr 2002, 48(4):204-209.
16. Starn A.L., Udall J.N. Iron deficiency anemia, pica, and restless legs syndrome in a teenage girl. Clin Pediatr (Phila) 2008, 47(1):83-85.
17. Brittenham G.M. Disorders of iron homeostasis: iron deficiency and overload. Hematology: basic principles and practice 2012, 441-442. Elsevier, Philadelphia. 6th edition. R. Hoffman, E.J. Benz, L.E. Silberstein (Eds.).
18. Lozoff B., Jimenez E., Wolf A.W. Long-term developmental outcome of infants with iron deficiency. N Engl J Med 1991, 325(10):687-694.
19. Lozoff B., Jimenez E., Hagen J., et al. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics 2000, 105(4):E51.
20. Lukowski A.F., Koss M., Burden M.J., et al. Iron deficiency in infancy and neurocognitive functioning at 19 years: evidence of long-term deficits in executive function and recognition memory. Nutr Neurosci 2010, 13(2):54-70.
21. Wang W., Bourgeois T., Klima J., et al. Iron deficiency and fatigue in adolescent females with heavy menstrual bleeding. Haemophilia 2013, 19(2):225-230.
22. Bruner A.B., Joffe A., Duggan A.K., et al. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet 1996, 348(9033):992-996.
23. Edgerton V.R., Gardner G.W., Ohira Y., et al. Iron-deficiency anaemia and its effect on worker productivity and activity patterns. Br Med J 1979, 2(6204):1546-1549.
24. Baker R.D., Greer F.R. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 2010, 126(5):1040-1050.
25. Buchanan G.R. The tragedy of iron deficiency during infancy and early childhood. J Pediatr 1999, 135(4):413-415.
26. Brugnara C., Adamson J., Auerbach M., et al. Iron deficiency: what are the future trends in diagnostics and therapeutics?. Clin Chem 2013, 59(5):740-745.
27. Buchanan G.R., Sheehan R.G. Malabsorption and defective utilization of iron in three siblings. J Pediatr 1981, 98(5):723-728.
28. Male C., Persson L.A., Freeman V., et al. Prevalence of iron deficiency in 12-mo-old infants from 11 European areas and influence of dietary factors on iron status (Euro-Growth study). Acta Paediatr 2001, 90(5):492-498.
29. Moy R.J. Prevalence, consequences and prevention of childhood nutritional iron deficiency: a child public health perspective. Clin Lab Haematol 2006, 28(5):291-298.
30. Brotanek J.M., Gosz J., Weitzman M., et al. Iron deficiency in early childhood in the United States: risk factors and racial/ethnic disparities. Pediatrics 2007, 120(3):568-575.
31. Brotanek J.M., Halterman J.S., Auinger P., et al. Iron deficiency, prolonged bottle-feeding, and racial/ethnic disparities in young children. Arch Pediatr Adolesc Med 2005, 159(11):1038-1042.
32. Nickerson H.J., Silberman T., Park R.W., et al. Treatment of iron deficiency anemia and associated protein-losing enteropathy in children. J Pediatr Hematol Oncol 2000, 22(1):50-54.
33. Salstrom J.L., Kent M., Liang X., et al. Toddlers with anasarca and severe anemia: a lesson in preventive medicine. Curr Opin Pediatr 2012, 24(1):129-133.
34. Goodnough L.T., Nemeth E., Ganz T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 2010, 116(23):4754-4761.
35. Buchanan G.R. Paucity of clinical trials in iron deficiency: lessons learned from study of VLBW infants. Pediatrics 2013, 131(2):e582-e584.
36. Clinicaltrials.gov. Comparison of NovaFerrum® vs Ferrous Sulfate treatment in young children with nutritional iron deficiency anemia (BESTIRON). 2013. Available at: Accessed November 21, 2013. http://www.clinicaltrials.gov/ct2/show/NCT01904864?term=iron+deficiency+anemia+children%26recr=Open%26rank=1.
37. Radtke H., Tegtmeier J., Rocker L., et al. Daily doses of 20 mg of elemental iron compensate for iron loss in regular blood donors: a randomized, double-blind, placebo-controlled study. Transfusion 2004, 44(10):1427-1432.
38. Jaber L., Rigler S., Taya A., et al. Iron polymaltose versus ferrous gluconate in the prevention of iron deficiency anemia of infancy. J Pediatr Hematol Oncol 2010, 32(8):585-588.
39. Hurrell R. Use of ferrous fumarate to fortify foods for infants and young children. Nutr Rev 2010, 68(9):522-530.
40. Hirve S., Bhave S., Bavdekar A., et al. Low dose 'Sprinkles'- an innovative approach to treat iron deficiency anemia in infants and young children. Indian Pediatr 2007, 44(2):91-100.
41. Gordeuk V.R., Brittenham G.M., McLaren C.E., et al. Carbonyl iron therapy for iron deficiency anemia. Blood 1986, 67(3):745-752.
42. Gordeuk V.R., Brittenham G.M., Hughes M., et al. High-dose carbonyl iron for iron deficiency anemia: a randomized double-blind trial. Am J Clin Nutr 1987, 46(6):1029-1034.
43. Farias I.L.G., Colpo E., Botton S.R., et al. Carbonyl iron reduces anemia and improves effectiveness of treatment in under six-year-old children. Revista Brasileira de Hematologia e Hemoterapia 2009, 31(3):125-131.
44. Andrews N.C., Ullrich C.K., Fleming M.D. Disorders of iron metabolism and sideroblastic anemia. Nathan and Oski's hematology of infancy and childhood 2009, 521-542. Sunders Elsevier, Philadelphia. 7th edition. S.H. Orkin, D.G. Nathan, D. Ginsburg (Eds.).
45. Sandoval C., Jayabose S., Eden A.N. Trends in diagnosis and management of iron deficiency during infancy and early childhood. Hematol Oncol Clin North Am 2004, 18(6):1423-1438.
46. Recommendations to prevent and control iron deficiency in the united states: centers for disease control and prevention. MMWR Recomm Rep 1998, 47:1-29.
47. Zlotkin S., Arthur P., Antwi K.Y., et al. Randomized, controlled trial of single versus 3-times-daily ferrous sulfate drops for treatment of anemia. Pediatrics 2001, 108(3):613-616.
48. Yewale V.N., Dewan B. Treatment of iron deficiency anemia in children: a comparative study of ferrous ascorbate and colloidal iron. Indian J Pediatr 2013, 80(5):385-390.
49. Kwiatkowski J.L., West T.B., Heidary N., et al. Severe iron deficiency anemia in young children. J Pediatr 1999, 135(4):514-516.
50. Reeves J.D., Yip R. Lack of adverse side effects of oral ferrous sulfate therapy in 1-year-old infants. Pediatrics 1985, 75(2):352-355.
51. Rimon E., Kagansky N., Kagansky M., et al. Are we giving too much iron? Low-dose iron therapy is effective in octogenarians. Am J Med 2005, 118(10):1142-1147.
52. Chertow G.M., Mason P.D., Vaage-Nilsen O., et al. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 2006, 21(2):378-382.
53. Chertow G.M., Mason P.D., Vaage-Nilsen O., et al. On the relative safety of parenteral iron formulations. Nephrol Dial Transplant 2004, 19(6):1571-1575.
54. Pinsk V., Levy J., Moser A., et al. Efficacy and safety of intravenous iron sucrose therapy in a group of children with iron deficiency anemia. Isr Med Assoc J 2008, 10(5):335-338.
55. Crary S.E., Hall K., Buchanan G.R. Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. Pediatr Blood Cancer 2011, 56(4):615-619.
56. Gozzard D. When is high-dose intravenous iron repletion needed? Assessing new treatment options. Drug Des Devel Ther 2011, 5:51-60.
57. Mamula P., Piccoli D.A., Peck S.N., et al. Total dose intravenous infusion of iron dextran for iron-deficiency anemia in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2002, 34(3):286-290.
58. Gasche C., Berstad A., Befrits R., et al. Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis 2007, 13(12):1545-1553.
59. Auerbach M., Strauss W., Auerbach S., et al. Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min. Am J Hematol 2013, 88(11):944-947.
60. Hassan N., Cahill J., Rajasekaran S., et al. Ferumoxytol infusion in pediatric patients with gastrointestinal disorders: first case series. Ann Pharmacother 2011, 45(12):e63.
61. Auerbach M. Should intravenous iron be upfront therapy for iron deficiency anemia?. Pediatr Blood Cancer 2011, 56(4):511-512.
62. Onken J.E., Bregman D.B., Harrington R.A., et al. A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia. Transfusion 2014, 54:306-315.
63. Vadhan-Raj S., Strauss W., Ford D., et al. Efficacy and safety of IV ferumoxytol for adults with iron deficiency anemia previously unresponsive to or unable to tolerate oral iron. Am J Hematol 2014, 89:7-12.
64. Plummer E.S., Crary S.E., McCavit T.L., et al. Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. Pediatr Blood Cancer 2013, 60(11):1747-1752.
65. Patsopoulos N.A. A pragmatic view on pragmatic trials. Dialogues Clin Neurosci 2011, 13(2):217-224.
66. Naim M., Hunter J. Intravenous iron replacement - management in general practice. Aust Fam Physician 2010, 39(11):839-841.
67. Forman E. Goodbye oral iron therapy?. Pediatr Blood Cancer 2013, 60(11):1731.
68. (AAFP) AAoFP. Iron deficiency anemia. 2006. Available at: Accessed December 15, 2013. http://www.aafp.org/patient-care/clinical-recommendations/all/iron-deficiency-anemia.html.
69. American College of Obstetricians and Gynecologists ACOG Practice Bulletin no. 95: anemia in pregnancy. Obstet Gynecol 2008, 112(1):201-207.
70. Brugnara C., Schiller B., Moran J. Reticulocyte hemoglobin equivalent (Ret He) and assessment of iron-deficient states. Clin Lab Haematol 2006, 28(5):303-308.
71. Mast A.E., Blinder M.A., Dietzen D.J. Reticulocyte hemoglobin content. Am J Hematol 2008, 83(4):307-310.
72. Lerner N.B., Sills R. Iron deficiency anemia. Nelson textbook of pediatrics 2011, 1658. Elsevier, Philadelphia. 19th edition. R.M. Kliegman, B.F. Stanton, J.W. Gemelll (Eds.).
73. Heeney M.M. Anemia. Rudolph's pediatrics 2011, McGraw-Hill, New York, Available at:, Accessed November 4, 2013. http://accesspediatrics.mhmedical.com/content.aspx?bookid%3D455, A.M. Rudolph, G.E. Lister, L.R. First (Eds.).
74. Lee C.K., Tschudy M.M., Arcara K.M. Drug doses. The Harriet Lane handbook: a manual for pediatric house officers 2011, 830. Elsevier, Philadelphia. 19th edition. M.M. Tschudy, K.M. Arcara (Eds.).
75. Adamson J.W. Iron deficiency and other hypoproliferative anemias. Harrison's principles of internal medicine 2012, The McGraw-Hill Companies, Inc, Available at:, Accessed November 4, 2013. http://accessmedicine.mhmedical.com/content.aspx?bookid=331%26Sectionid%3D40726841, 18th edition. D.L. Longo, A.S. Fauci, D.L. Kasper (Eds.).
76. Lanzkowsky P. Iron-deficiency anemia. Manual of pediatric hematology and oncology 2011, 38-57. Elsevier, Philadelphia. 5th edition. P. Lanzkowsky (Ed.).